Please enable JavaScript to continue using this application.

Compare $JANX vs $SVRA | Chartloom

Compare

$JANX vs $SVRA

Janux Therapeutics Inc · Savara Inc

JANX

Janux Therapeutics Inc

SVRA

Savara Inc

Compare $JANX vs $SVRA

Comparing Janux Therapeutics Inc and Savara Inc

JANXJanux Therapeutics Inc

SVRASavara Inc

JANXJanux Therapeutics Inc

Market cap

$1.12B

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

63.26x

Rev growth (TTM)

5367.0%

YTD performance

34.7%

52W performance

-24.0%

FCF yield

-3.7%

SVRASavara Inc

Market cap

$1.01B

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

22.71x

Rev growth (TTM)

—

YTD performance

-12.8%

52W performance

41.8%

FCF yield

-11.0%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

JANX

SVRA

Detailed metrics comparison

JANX

Janux Therapeutics Inc

SVRA

Savara Inc

Market Cap

JANX$1.12B

SVRA$1.01B

Enterprise Value

JANX$1.09B

SVRA$997M

Price

JANX$18.39

SVRA$4.92

P/E Ratio

JANXN/A

SVRAN/A

P/S Ratio

JANX46.73x

SVRA3,801.01x

EV/Sales

JANX45.57x

SVRA3,756.05x

EV/EBITDA

JANX0.00x

SVRA0.00x

P/B Ratio

JANX1.12x

SVRA6.88x

P/FCF Ratio

JANXN/A

SVRAN/A

EV/FCF

JANX-26.09x

SVRA-9.01x

PEG Ratio

JANXN/A

SVRAN/A

Forward P/E (NTM)

JANXN/A

SVRAN/A

Forward P/S (NTM)

JANX63.26x

SVRA22.71x

Revenue (TTM)

JANX$24M

SVRA$0

Revenue Growth (YoY)

JANX5367.0%

SVRAN/A

Forward Rev Growth

JANX-76.0%

SVRA3388.8%

Gross Margin (TTM)

JANX0.0%

SVRA0.0%

Operating Margin (TTM)

JANX0.0%

SVRA0.0%

EBITDA Margin (TTM)

JANX-590.2%

SVRA0.0%

Net Margin (TTM)

JANX-427.5%

SVRA0.0%

FCF Margin (TTM)

JANX-174.7%

SVRAN/A

Net Income (TTM)

JANX$-103M

SVRA$-139M

FCF (TTM)

JANX$-42M

SVRA$-111M

EPS (TTM)

JANX-$1.63

SVRA-$0.55

ROE (TTM)

JANX-1079.0%

SVRA-9028.0%

ROA (TTM)

JANX-1010.0%

SVRA-6895.0%

ROIC (TTM)

JANX-1079.0%

SVRA-7560.0%

Cash

JANX$28M

SVRA$42M

Debt

JANX$0

SVRA$30M

Net Cash/Debt

JANX$28M

SVRA$12M

Current Ratio (TTM)

JANX16.35x

SVRA10.13x

Quick Ratio (TTM)

JANX16.25x

SVRA10.00x

Debt/Equity (TTM)

JANX0.00x

SVRA0.21x

Debt/Assets (TTM)

JANX0.0%

SVRA0.0%

Interest Coverage (TTM)

JANXN/A

SVRAN/A

Net Debt/EBITDA (TTM)

JANX0.00x

SVRA0.00x

Beta

JANX2.42

SVRA0.28

52W Performance

JANX-24.0%

SVRA41.8%

YTD Performance

JANX34.7%

SVRA-12.8%

% from 52W High

JANX-48.0%

SVRA-29.8%

% from 52W Low

JANX51.7%

SVRA46.9%

Asset Turnover (TTM)

JANX0.02x

SVRA0.00x

FCF Yield (TTM)

JANX-3.7%

SVRA-11.0%

Earnings Yield (TTM)

JANX-9.1%

SVRA-13.8%

Dividend Yield (TTM)

JANXN/A

SVRAN/A

Rule of 40

JANX5,192.3

SVRA0.0

EV/GP/RG

JANXN/A

SVRAN/A

Ticker research

View JANX research View SVRA research

Metric	JANX Janux Therapeutics Inc	SVRA Savara Inc
Market & Valuation
Market Cap	$1.12B	$1.01B
Enterprise Value	$1.09B	$997M
Price	$18.39	$4.92
P/E Ratio	N/A	N/A
P/S Ratio	46.73x	3,801.01x
EV/Sales	45.57x	3,756.05x
EV/EBITDA	0.00x	0.00x
P/B Ratio	1.12x	6.88x
P/FCF Ratio	N/A	N/A
EV/FCF	-26.09x	-9.01x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	63.26x	22.71x
Revenue & Growth
Revenue (TTM)	$24M	$0
Revenue Growth (YoY)	5367.0%	N/A
Forward Rev Growth	-76.0%	3388.8%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-590.2%	0.0%
Net Margin (TTM)	-427.5%	0.0%
FCF Margin (TTM)	-174.7%	N/A
Net Income (TTM)	$-103M	$-139M
FCF (TTM)	$-42M	$-111M
EPS (TTM)	-$1.63	-$0.55
ROE (TTM)	-1079.0%	-9028.0%
ROA (TTM)	-1010.0%	-6895.0%
ROIC (TTM)	-1079.0%	-7560.0%
Financial Health
Cash	$28M	$42M
Debt	$0	$30M
Net Cash/Debt	$28M	$12M
Current Ratio (TTM)	16.35x	10.13x
Quick Ratio (TTM)	16.25x	10.00x
Debt/Equity (TTM)	0.00x	0.21x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	2.42	0.28
52W Performance	-24.0%	41.8%
YTD Performance	34.7%	-12.8%
% from 52W High	-48.0%	-29.8%
% from 52W Low	51.7%	46.9%
Efficiency & Yields
Asset Turnover (TTM)	0.02x	0.00x
FCF Yield (TTM)	-3.7%	-11.0%
Earnings Yield (TTM)	-9.1%	-13.8%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	5,192.3	0.0
EV/GP/RG	N/A	N/A
Ticker research	View JANX research	View SVRA research

Valuation

P/S Ratio

JANX

46.73x

SVRA

3,801.01x

EV/FCF

JANX

-26.09x

SVRA

-9.01x

Growth & revenue

Revenue Growth TTM

JANX

5367.0%

Forward Revenue Growth

SVRA

3388.8%

JANX

-76.0%

Profitability & performance

Gross Margin

JANX

0.0%

SVRA

0.0%

ROE

JANX

-1079.0%

SVRA

-9028.0%

FCF Yield %

JANX

-3.7%

SVRA

-11.0%

52-Week Performance

SVRA

41.8%

JANX

-24.0%

Detailed metrics comparison

JANX

Janux Therapeutics Inc

SVRA

Savara Inc

Market Cap

JANX$1.12B

SVRA$1.01B

Enterprise Value

JANX$1.09B

SVRA$997M

Price

JANX$18.39

SVRA$4.92

P/E Ratio

JANXN/A

SVRAN/A

P/S Ratio

JANX46.73x

SVRA3,801.01x

EV/Sales

JANX45.57x

SVRA3,756.05x

EV/EBITDA

JANX0.00x

SVRA0.00x

P/B Ratio

JANX1.12x

SVRA6.88x

P/FCF Ratio

JANXN/A

SVRAN/A

EV/FCF

JANX-26.09x

SVRA-9.01x

PEG Ratio

JANXN/A

SVRAN/A

Forward P/E (NTM)

JANXN/A

SVRAN/A

Forward P/S (NTM)

JANX63.26x

SVRA22.71x

Revenue (TTM)

JANX$24M

SVRA$0

Revenue Growth (YoY)

JANX5367.0%

SVRAN/A

Forward Rev Growth

JANX-76.0%

SVRA3388.8%

Gross Margin (TTM)

JANX0.0%

SVRA0.0%

Operating Margin (TTM)

JANX0.0%

SVRA0.0%

EBITDA Margin (TTM)

JANX-590.2%

SVRA0.0%

Net Margin (TTM)

JANX-427.5%

SVRA0.0%

FCF Margin (TTM)

JANX-174.7%

SVRAN/A

Net Income (TTM)

JANX$-103M

SVRA$-139M

FCF (TTM)

JANX$-42M

SVRA$-111M

EPS (TTM)

JANX-$1.63

SVRA-$0.55

ROE (TTM)

JANX-1079.0%

SVRA-9028.0%

ROA (TTM)

JANX-1010.0%

SVRA-6895.0%

ROIC (TTM)

JANX-1079.0%

SVRA-7560.0%

Cash

JANX$28M

SVRA$42M

Debt

JANX$0

SVRA$30M

Net Cash/Debt

JANX$28M

SVRA$12M

Current Ratio (TTM)

JANX16.35x

SVRA10.13x

Quick Ratio (TTM)

JANX16.25x

SVRA10.00x

Debt/Equity (TTM)

JANX0.00x

SVRA0.21x

Debt/Assets (TTM)

JANX0.0%

SVRA0.0%

Interest Coverage (TTM)

JANXN/A

SVRAN/A

Net Debt/EBITDA (TTM)

JANX0.00x

SVRA0.00x

Beta

JANX2.42

SVRA0.28

52W Performance

JANX-24.0%

SVRA41.8%

YTD Performance

JANX34.7%

SVRA-12.8%

% from 52W High

JANX-48.0%

SVRA-29.8%

% from 52W Low

JANX51.7%

SVRA46.9%

Asset Turnover (TTM)

JANX0.02x

SVRA0.00x

FCF Yield (TTM)

JANX-3.7%

SVRA-11.0%

Earnings Yield (TTM)

JANX-9.1%

SVRA-13.8%

Dividend Yield (TTM)

JANXN/A

SVRAN/A

Rule of 40

JANX5,192.3

SVRA0.0

EV/GP/RG

JANXN/A

SVRAN/A

Ticker research

View JANX research View SVRA research

Metric	JANX Janux Therapeutics Inc	SVRA Savara Inc
Market & Valuation
Market Cap	$1.12B	$1.01B
Enterprise Value	$1.09B	$997M
Price	$18.39	$4.92
P/E Ratio	N/A	N/A
P/S Ratio	46.73x	3,801.01x
EV/Sales	45.57x	3,756.05x
EV/EBITDA	0.00x	0.00x
P/B Ratio	1.12x	6.88x
P/FCF Ratio	N/A	N/A
EV/FCF	-26.09x	-9.01x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	63.26x	22.71x
Revenue & Growth
Revenue (TTM)	$24M	$0
Revenue Growth (YoY)	5367.0%	N/A
Forward Rev Growth	-76.0%	3388.8%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-590.2%	0.0%
Net Margin (TTM)	-427.5%	0.0%
FCF Margin (TTM)	-174.7%	N/A
Net Income (TTM)	$-103M	$-139M
FCF (TTM)	$-42M	$-111M
EPS (TTM)	-$1.63	-$0.55
ROE (TTM)	-1079.0%	-9028.0%
ROA (TTM)	-1010.0%	-6895.0%
ROIC (TTM)	-1079.0%	-7560.0%
Financial Health
Cash	$28M	$42M
Debt	$0	$30M
Net Cash/Debt	$28M	$12M
Current Ratio (TTM)	16.35x	10.13x
Quick Ratio (TTM)	16.25x	10.00x
Debt/Equity (TTM)	0.00x	0.21x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	2.42	0.28
52W Performance	-24.0%	41.8%
YTD Performance	34.7%	-12.8%
% from 52W High	-48.0%	-29.8%
% from 52W Low	51.7%	46.9%
Efficiency & Yields
Asset Turnover (TTM)	0.02x	0.00x
FCF Yield (TTM)	-3.7%	-11.0%
Earnings Yield (TTM)	-9.1%	-13.8%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	5,192.3	0.0
EV/GP/RG	N/A	N/A
Ticker research	View JANX research	View SVRA research